Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD228 antibodies and antibody-drug conjugates

Anti-CD228 antibodies and antibody-drug conjugates

US Patent 11617798 · Granted Apr 4, 2023

Estimated economic value: $410,768,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αVβ6 antibodies and antibody-drug conjugates2025
CD47 antibodies and uses thereof for treating cancer2024
Anti-AVB6 antibodies and antibody-drug conjugates2023
Glypican 3 antibodies and conjugates thereof2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Anti-NTB-A antibodies and related compositions and methods2022
Anti-NTB-A antibodies and related compositions and methods2022
CD47 antibodies and uses thereof for treating cancer2021
BCMA antibodies and use of same to treat cancer and immunological disorders2021
CD123 antibodies and conjugates thereof2021
CD48 antibodies and conjugates thereof2020